Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
10/22/2008 | EP1981882A1 Amide substituted quinolines |
10/22/2008 | EP1981880A2 Use of 4-imidazole derivatives for cns disorders |
10/22/2008 | EP1981873A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof |
10/22/2008 | EP1981869A1 New citrate salt of an indole derivative and its pharmaceutical use |
10/22/2008 | EP1981865A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
10/22/2008 | EP1981864A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
10/22/2008 | EP1981862A2 Lanthionine-related compounds for the treatment of inflammatory diseases |
10/22/2008 | EP1981840A1 Process for manufacturing entacapone |
10/22/2008 | EP1981839A1 Non-natural amino acid derivatives |
10/22/2008 | EP1981596A2 Novel compounds |
10/22/2008 | EP1981546A2 Enzyme replacement therapy for treating lysosomal storage diseases |
10/22/2008 | EP1981542A1 Upregulation of adamts4 protease activity for the treatment of alzheimer's disease |
10/22/2008 | EP1981529A2 Colony stimulating factors for the treatment of coma and neurotoxicity |
10/22/2008 | EP1981522A2 Compositions and methods for enhancing neuronal plasticity and regeneration |
10/22/2008 | EP1981518A1 Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent |
10/22/2008 | EP1981504A2 Thiadiazole derivatives for the treatment of neuro degenerative diseases |
10/22/2008 | EP1981500A1 Pharmaceutical use of 2-hydroxy-3- [5-(morpholin-4-ylmethyl) pyridine-2-yl]-1h- indole-5-carbonitrile as a free base or salts |
10/22/2008 | EP1981499A1 Use of 2-imidazoles for the treatment of cns disorders |
10/22/2008 | EP1981498A2 Use of 2-imidazoles for the treatment of cns disorders |
10/22/2008 | EP1981497A2 Use of substituted 2-imidazole of imidazoline derivatives |
10/22/2008 | EP1697359B1 Muscarinic agonists as therapeutic compounds |
10/22/2008 | EP1677823B1 Botulinum toxin treatments of neurological and neuropsychiatric disorders |
10/22/2008 | EP1675573B1 Controlled release sterile injectable aripiprazole formulation and method |
10/22/2008 | EP1660461B1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
10/22/2008 | EP1594864B1 Benzofuran oxyethylamines serving as antidepressant drugs and anxiolytic drugs |
10/22/2008 | EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
10/22/2008 | EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
10/22/2008 | EP1408984B1 Organo-phosphorous compounds for activating gamma/delta t cells |
10/22/2008 | EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists |
10/22/2008 | CN101291939A Thiazolo[4,5-C]pyridine derivatives as mGluR5 receptor antagonists |
10/22/2008 | CN101291937A Fused tricyclic mgiur1 antagonists as therapeutic agents |
10/22/2008 | CN101291936A Fused tricyclic mglur1 antagonists as therapeutic agents |
10/22/2008 | CN101291933A Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
10/22/2008 | CN101291931A 9-azabicyclo [3.3.1]nonane derivatives as monoamine reuptake inhibitors |
10/22/2008 | CN101291925A Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
10/22/2008 | CN101291913A Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
10/22/2008 | CN101291680A Antioxidant and Fe2+chelating properties of herbal extracts |
10/22/2008 | CN101291670A Carbazole derivatives as functional 5-HT6 ligands |
10/22/2008 | CN101291665A Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
10/22/2008 | CN101291661A 2-aminoalcohols for the treatment of neurodegenerative diseases |
10/22/2008 | CN101289481A Synthesis of N-aryl-3-(4-beta-D-allopyranoside phenyl)-5-formyl isoxazole-4-methane amide |
10/22/2008 | CN101289472A Process for separating matrine-like total alkaloids form Chinese medicament extract |
10/22/2008 | CN101289471A Process for separating total alkaloids of corydalis rhizome form Chinese medicament extracting solution of corydalis rhizome |
10/22/2008 | CN101289448A Method for preparing 1,3,7,9-tetramethyl uric acid |
10/22/2008 | CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents |
10/22/2008 | CN101289428A Biaryl substituted triazoles as sodium channel blockers |
10/22/2008 | CN101288771A Preparation method of anti-human Nogo-66 receptor protein vaccine and application thereof |
10/22/2008 | CN101288768A Medicine composition for treating progressive nerve degeneration disease |
10/22/2008 | CN101288766A Chinese traditional medicine for treating depression |
10/22/2008 | CN101288764A Medicine for relieving or neutralizing effect of alcohol, protecting liver and nourishing stomach |
10/22/2008 | CN101288761A Chinese tmedicine preparation for treating depression and its preparation method |
10/22/2008 | CN101288751A Effervescence nutrient solution for child attention deficiency syndrome and its special bottle |
10/22/2008 | CN101288742A Medicinal composition for preventing birth defect and improving memory |
10/22/2008 | CN101288741A Medicinal composition for preventing birth defect and improving memory and intelligence |
10/22/2008 | CN101288731A Medicine composition for preventing birth defect and improving memory |
10/22/2008 | CN101288730A Medicine composition for preventing birth defect and improving memory |
10/22/2008 | CN101288725A Decoction for treating nervous headache |
10/22/2008 | CN101288724A Chinese medicinal preparation for treating persistent dysentery |
10/22/2008 | CN101288720A Chinese medicinal composition for treating syringomyelia and preparation method thereof |
10/22/2008 | CN101288718A Externally used liniment drug for treating trigeminal neuralgia |
10/22/2008 | CN101288717A Medicine composition for preventing birth defect and improving memory |
10/22/2008 | CN101288702A Mongolian medicine for treating sleep disorder |
10/22/2008 | CN101288698A Medicinal composition for preventing birth defect and improving memory |
10/22/2008 | CN101288693A Multifunctional health-care medical pillow for middle aged and old people |
10/22/2008 | CN101288689A Orally-taken traditional Chinese medicines for treating light headedness |
10/22/2008 | CN101288680A Preparation method of instant tuckahoe granule |
10/22/2008 | CN101288679A Dissolving and reducing generation method of nano pearl powder |
10/22/2008 | CN101288671A Use of Triperugium wilfordii monomeric compound for increasing gene expression efficiency mediated by adeno-associated virus vector and subsidiarily treating neurodegenerative disease |
10/22/2008 | CN101288648A Easy-to-administrate oxiracetam granular formulation and preparation method |
10/22/2008 | CN101288639A Method for purifying pearl hydrolysate using hyperfiltration and nanofiltration |
10/22/2008 | CN101288475A Production method of flavor panax ginseng |
10/22/2008 | CN100427486C Novel benzimidazole derivatives |
10/22/2008 | CN100427484C 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts |
10/22/2008 | CN100427095C Injection for venocylsis of diluted Diltiazem containing calcium channel blocker |
10/22/2008 | CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
10/22/2008 | CN100427089C Use of indazole derivatives for the treatment of neuropathic pain |
10/22/2008 | CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
10/21/2008 | US7439393 Phenethanolamine derivatives for treatment of respiratory diseases |
10/21/2008 | US7439364 Process for the synthesis of derivatives of halo-[2,3-F] quinoline |
10/21/2008 | US7439363 Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors |
10/21/2008 | US7439362 For treatment of acne, seborrhea, androgenic alopecia. hirsutism, and breast cancer |
10/21/2008 | US7439356 Substituted indan derivatives |
10/21/2008 | US7439264 Therapeutic compounds |
10/21/2008 | US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
10/21/2008 | US7439247 Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
10/21/2008 | US7439245 e.g. 1-(3-Phenylsulfonyl-phenyl)piperazine; serotonin receptor modulator; anxiolytic agent, antidepressant, cognition activator; schizophrenia, obesity, Alzheimer's disease |
10/21/2008 | US7439244 e.g. 8-(4-(4-Fluorobenzyl)-piperazin-1-yl)-3-phenylsulfonylquinoline; serotonin receptor modulator; antidepressant, anxiolytic agent, cognition activator; schizophrenia, obesity, Alzheimer's disease |
10/21/2008 | US7439243 Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders |
10/21/2008 | US7439240 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example |
10/21/2008 | US7439237 e.g. 1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-oxo-2-[4-(2-piperidin-1-yl-ethyl)-piperidin-1-yl]-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine or cluster headaches, non-insulin-dependent diabetes |
10/21/2008 | US7439236 Pharmaceutical composition for the treatment of CNS and other disorders |
10/21/2008 | US7439063 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
10/21/2008 | US7438927 Methods of treatment using a gastric retained gabapentin dosage |
10/21/2008 | US7438903 Fine particle sizes; nanostructure; in mixture with oil, water carriers, excipients; oral diseases; cognition activators; hypotensive agents; immunology diseases; blood disorders |
10/21/2008 | CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
10/21/2008 | CA2390284C Apparatus and method for preparing microparticles |
10/21/2008 | CA2270893C N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
10/21/2008 | CA2247998C Fragments of cr1 and their use |
10/21/2008 | CA2210913C Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives |
10/21/2008 | CA2169071C Methods for modulating the human sexual response |